Gdansk / Toronto / Lausanne / Vienna / Chicago / /
Country
Poland / Switzerland / Austria / United States / Canada / /
Facility
Research Institute / Institute of Animal Breeding / Samuel Lunenfeld Research Institute / Biotechnology University of Gdansk / University Avenue / University of Toronto / Mount Sinai Hospital / Veterinary Medical University of Vienna / Medical University of Gdansk / Swiss Institute / University of Chicago / Medical University of Vienna / /
IndustryTerm
kinase active site / /
MedicalCondition
completely abolished leukemia / /
Organization
Department of Molecular Genetics / Institute of Animal Breeding and Genetics / Intercollegiate Faculty / The University of Chicago / University of Toronto / Toronto / Samuel Lunenfeld Research Institute / University of Vienna / Ecole polytechnique / Research Institute for Molecular Pathology / Center for Molecular Medicine / Biotechnology University of Gdansk / Austrian Academy of Sciences / Medical University of Gdansk / Swiss Institute for Experimental / Division of Hematology and Hemostaseology / Mount Sinai Hospital / /
Person
Ludwig Boltzmann Cluster Oncology / Bohr Gasse / /
Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesis Florian Grebien1,#, Oliver Hantschel1,8,#,&, John Wojcik2, Ines Kaupe1, Boris Kovacic3,9, Arkadiusz M. Wyrzucki2,4, Gerald D. Gish5, Sabine Cerny-Reit